- 专利标题： USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, AND NICOTINAMIDE MONONUCLEOTIDE, REDUCED NICOTINYL COMPOUNDS, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA FOR HEALTHY DEVELOPMENT
-
申请号： US17114864申请日： 2020-12-08
-
公开(公告)号： US20210228604A1公开(公告)日： 2021-07-29
- 发明人: Ryan Dellinger , Troy Rhonemus , Mark Morris , Dietrich Conze , Amy Boileau
- 申请人： ChromaDex, Inc.
- 申请人地址： US CA Irvine
- 专利权人： ChromaDex, Inc.
- 当前专利权人： ChromaDex, Inc.
- 当前专利权人地址： US CA Irvine
- 主分类号： A61K31/706
- IPC分类号： A61K31/706 ; A61K31/51 ; A23L33/10 ; A61K31/4415 ; A61K31/455 ; A61K31/525 ; A61K31/7064 ; A23L33/19 ; A23L33/00 ; A23L33/15 ; A61K45/06 ; A61K47/42
摘要：
Methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.
公开/授权文献
信息查询
